Coronavirus continues to cause havoc globally and in Australia – but here are five reasons for optimism
By Fenwickefinancial On July 28, 2021
It seems the bad news on coronavirus doesn’t let up. The lockdown in NSW looks like going longer. There is endless debate about whether governments are doing the right thing, whether the vaccines will work and when we can reopen. And coronavirus cases are on the rise again, globally posing risks to the economic recovery. But there remains light at the end of the tunnel. This note looks at five reasons for optimism.
But first, the bad news
-First, global daily new coronavirus cases are rising again.
-This has left impacted lowly vaccinated countries little choice but to tighten restrictions & enter lockdowns (to avoid overwhelming healthcare systems). This includes Asian countries that managed coronavirus well last year.
-Much of the latest upswing is occurring in relatively highly vaccinated developed countries – notably in the UK, Europe and the US – where it’s particularly affecting unvaccinated younger people, but also some vaccinated people. With only 50% or so of the population fully vaccinated that still leaves these countries vulnerable should new cases rise rapidly, causing a surge in hospitalisations. Some lowly vaccinated US states are at high risk, eg, Texas is running out of ICU beds. This in turn is seeing debate about a return to some restrictions, with some doing so – eg Singapore and the return of mask mandates in some US states.
-The Delta variant of coronavirus responsible for much of the recent surge in cases is 2-3 times more transmissible than the original version with a shorter incubation period.
-Partly reflecting this, after more than four weeks in lockdown the number of new cases in NSW has continued to trend up, albeit being very low by global standards.
-The lockdowns seen since May and in NSW (assuming the NSW lockdown goes into August) are estimated to cost $12bn, resulting in a contraction in Australian September quarter GDP of around -0.7%, and risking a return to recession. Our Australian Economic Activity Tracker which combines weekly data has fallen sharply this month.
-Only 14% of the global population has been vaccinated with two doses, & in Australia its only 13%. Which means there is a long way to go to reach herd immunity – which may require 80% to be fully vaccinated given the Delta variant.
Five reasons for optimism
First, lockdowns still work against the Delta variant. This is being seen in various Asian countries and in Australia, with Victoria, Queensland, WA & SA all managing Delta outbreaks with short lockdowns and able to reopen again without getting everyone vaccinated. The key difference versus NSW was that they started earlier in terms of the new daily case load (1-10 a day v nearly 30 in NSW) & went harder up front. SA has ended its snap lockdown & Victoria has announced the end of its.
And while it may take longer in NSW because it started later, new cases are not exploding despite the Delta variant. In fact, the rate of increase is slower than seen in the Victorian wave from mid-last year. This suggests the NSW lockdown is helping – it started earlier than Victoria’s did last year. And having had 3.5 million vaccines already administer in NSW may also be helping. So, while the lockdown is taking longer than expected and may have to be tightened – it does appear to be helping & the experience of other states tells us they still work. They just need to start earlier and harder if we want them to be short.
Second, vaccines are working. While the UK, US and Europe have seen a rise in new cases, hospitalisations and new deaths are more subdued this time around. This is clear in the UK – which has also seen new cases fall in the last week (vaccines helping slow the spread or it could just be an aberration?)
This is all consistent with vaccines being 90% plus effective in preventing the need for hospitalisation and deaths, even though they’re less effective in preventing infection (61% for AstraZeneca and 82% for Pfizer/Moderna with respect to Delta) & only 47% effective in preventing onwards transmission based on UK data. The success of the vaccines can also be seen in the US with per capita new cases and hospitalisations in the top quartile of vaccinated states up to 25% below that in the bottom quartile of unvaccinated states. Ideally, these countries should be waiting till they reach 80% or so vaccinated before fully reopening (as Singapore is) to reduce the risk of problems with overwhelmed hospitals. But with older and more at-risk people close to being fully vaccinated this should be manageable with restrictions (like masks & distancing) rather than hard lockdowns. And so, the recovery should be able to continue.
Third, the experience of the last year has demonstrated repeatedly that once lockdowns end economic activity rebounds rapidly propelled in part by pent up demand. We are starting to see this in Europe where confidence and business conditions have rebounded above that in Australia and the US thanks to its reopening (after a double dip recession in the December and March quarters). It has been seen repeatedly in Australia after the numerous lockdowns (including the 3-4 month Victorian lockdown last year). Ramped up Government support points to the same happening again in NSW through the December quarter serving to get the recovery back on track.
Fourth, the threat posed by Delta will add to pressure for more fiscal stimulus and easier for longer monetary policy. It will increase pressure in the US to pass President Biden’s $4 trillion eight-year American Jobs and Families Plans and will help keep the Fed dovish. Pressure for more stimulus (back to JobKeeper) is also ramping up in Australia and it will likely see the RBA delay its decision to reduce bond buying.
Finally, the pace of vaccination in Australia is ramping up rapidly. Last week was the first with over 1 million vaccinations. At the rate of 1 million vaccines a week Australia will hit 60% vaccinated by around year end and 80% by mid-March. If we ramp it up to 1.5 million doses a week as global vaccine production ramps up, it will be 60% by mid-November and 80% by early January. Beyond around 80% fully vaccinated we should (new mutations aside) be able to start to live with coronavirus in the community without overwhelming the health care system and keeping deaths down. This is the only way to end the snap lockdowns in a way that does not risk Australians’ health and the economy. Because as we saw last year, countries that were lax in controlling coronavirus and allowed deaths to surge saw a bigger hit to their economies.
Implications for investors
The renewed surge in coronavirus cases poses a short-term risk to share markets and other cyclical trades like the Australian dollar. However, there is a danger in over emphasising this as we remain of the view that the economic recovery globally and in Australia will continue as lockdowns end in the short term and increased vaccination allows a more sustained reopening over the next 12 months. Share markets have proven relatively resilient so far because there is now more evidence of the ability of science & medicine to control the virus, the Delta variant is seen as driving easier for longer fiscal and monetary policy and US June quarter earnings results are again coming in far stronger than expected.
Written by Dr Shane Oliver, Head of Investment Strategy and Economics and Chief Economist at AMP Capital is responsible for AMP Capital’s diversified investment funds. He also provides economic forecasts and analysis of key variables and issues affecting, or likely to affect, all asset markets.
Important note: While every care has been taken in the preparation of this article, AMP Capital Investors Limited (ABN 59 001 777 591, AFSL 232497) and AMP Capital Funds Management Limited (ABN 15 159 557 721, AFSL 426455) makes no representations or warranties as to the accuracy or completeness of any statement in it including, without limitation, any forecasts. Past performance is not a reliable indicator of future performance. This article has been prepared for the purpose of providing general information, without taking account of any particular investor’s objectives, financial situation or needs. An investor should, before making any investment decisions, consider the appropriateness of the information in this article, and seek professional advice, having regard to the investor’s objectives, financial situation and needs. This article is solely for the use of the party to whom it is provided.